Charleston, SC -- (SBWIRE) -- 10/07/2013 -- The Team of advisers at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer. Have a look at: Telkonet, Inc. (OTCBB:TKOI), VUZIX CORP CMN STK (OTCBB:VUZI), International Stem Cell Corp (OTCMKTS:ISCO), Transgenomic Inc (OTCMKTS:TBIO)
Telkonet, Inc. (OTCBB:TKOI) remained a bear for the day as it reported the loss of -14.51% and closed at $0.218 after gaining total volume of 1.59 million shares. Its introductory price for the day was $0.26. So far, the company’s stock is up +29.41% in the three months period. In the last 6 months of trade it reported a gain of +29.41%.
Telkonet, Inc. provides EcoSmart energy management technology and EthoStream high-speed Internet access solutions primarily in the United States. Its EcoSmart suite of products provides savings, management, and reporting of a building's room-by-room energy consumption solutions.
Has TKOI Found The Bottom and Ready To Move Up? Find Out Here
VUZIX CORP CMN STK (OTCBB:VUZI) reported the gain of +1.83% and closed at $ 2.23 with the total traded volume of 88,453 shares. The stock's opening price was $ 2.22. The company has a total market capitalization of $ 20.89 million.
The 52-week price range of the stock remained $1.75 - $9.75, while during last trade its minimum price was $2.16 and it gained its highest price of $2.25. Company's last 5 days shows a down turn with a decline of -1.76%. Vuzix Corporation engages in the design, manufacture, marketing, and sale of products for use in the consumer, and media and entertainment markets.
For How Long VUZI will Fight for Profitability? Read This Trend Analysis report
International Stem Cell Corp (OTCMKTS:ISCO) ended its day with the declining stream with the plunge of -3.23% and closed at the price of $0.150 after opening at $0.16. Stock traded during its last trading session with the total volume of 701,074 shares, as compared to its average volume of 559,451 shares.
During the previous session, the company’s minimum price was $0.15, while it touched its highest price for the day at $0.16. ISCO’s beta value stands at -0.03 points. International Stem Cell Corporation, a developmental stage biotechnology company, engages in the development and commercialization of therapeutic, biomedical, and cosmeceutical products in the United States and internationally.
Will ISCO Get Buyers Even After The Recent Rally? Find Out Here
Transgenomic Inc (OTCMKTS:TBIO) reported the increase of +8.70%, to close at $0.500, with the overall traded volume of 828,497 shares.
So far, in the past three months, the stock is up +19.05%. The 52-week range for the stock is $0.30 and $0.97 and during the previous trading session the stock touched its highest price at $0.50. Its introductory price for the day was $0.46. Transgenomic, Inc. operates as a biotechnology company in the United States, Italy, the United Kingdom, Germany, France, and internationally. Its Clinical Laboratories segment offers genetic testing services for cardiology, neurology, mitochondrial disorders, and oncology.
What was the Moving Force behind TBIO On Bullish Run? Read This Research Report
Our team of advisers here at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the CapitalEquityReport.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
Read Full Disclaimer at: http://capitalequityreport.com/about-us/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)